If steatosis is the atherosclerosis of the liver, are statins the “aspirin” for steatosis?

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 2012 Italy English Publisher:Elsevier BVJournal:Digestive and Liver Disease, volume 44, pages 451-452 (issn: 1590-8658,

Copyright policy )

Authors: A. Lonardo A; LORIA, Paola;

doi: 10.1016/j.dld.2012.02.020

pmid: 22487461

handle: 11380/761049

If steatosis is the atherosclerosis of the liver, are statins the “aspirin” for steatosis?

- Summary
- Subjects
- Metrics

Abstract

Not available

Country

Italy

Related Organizations

University of Modena and Reggio Emilia
Italy

Keywords

Male, Tumor Necrosis Factor-alpha, Anticholesteremic Agents, Fatty Liver; Statins; HCC; NASH; Metabolic Syndrome; Insulin resistance, Fatty Liver, Heptanoic Acids, Non-alcoholic Fatty Liver Disease, Atorvastatin, Humans, Female, Pyrroles, Dyslipidemias

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	13
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%